Autism Disorder and Treatment Market – Overview:
Autism spectrum disorder (ASD) is a group of complex neurological disorders characterized by varied patterns of behaviour, and problems with social communication and interaction. The major signs, and symptoms of ASD includes compulsive behaviour, inappropriate social interaction, learning disability, anxiety, sensitivity to sound, repetitive movements, and many others. As per the 2017 reviewed data suggested by Centers for disease control and prevention, it is observed that nearly 1 in 68 children has been diagnosed with autism spectrum disorder (ASD). It is also reported that the condition is 4.5 times more common among boys than among girls.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1605 .
Rising awareness about the condition is the key factor driving the autism disorder and treatment market. From the current scenario it is found that various government or privately held societies are continuously putting efforts to make people aware of autism disorder. For instance, on June 1, 2017, the U.S. based Autism Society conducted 49th annual conference focuses on quality of life. Rising research & development activities have also attracted a great deal of attention. The Autism CARES Act extended federal coverage of autism research activities by five years with $1.3 billion funding. Despite these significant driving factors, there are some issues associated with market. Patent expiration of drugs is expected to decline the market growth in near future.
Products in the pipeline:
Due to the rising demand, and to meet the untapped and unmet needs various companies are coming up with innovative autism treatment products. For instance, RG7314, by F. Hoffmann-La Roche Ltd, is a potent small molecule antagonist of the V1A vasopressin receptor is under clinical trials to treat Autism spectrum disorders. Various other companies such as, APeT Holding BV, BioCrea GmbH, Coronis Partners Ltd., Curemark LLC, Heptares Therapeutics Limited, Intra-Cellular Therapies Inc., Saniona AB, and others are continuously putting efforts to introduce new effective drugs to treat autism , and related problems. Global key Players : GlaxoSmithKline plc (U.K), pfizer inc. (U.S.), Eli Lilly and Company (U.S.). Allergan (Ireland), Merck & CO Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Consern Pharma Private Limited (India) are some of the prominent players profiled in MRFR Analysis and are at the forefront of competition in the Global Autism Disorder and Treatment Market.
Major TOC Global Autism Disorder and Treatment Market Research Report- Forecast To 2022:
1.2 Additional Facts & Figures
1.3 Scope of Study
1.4 Research Objective
1.5 Assumptions & Limitations
2 RESEARCH METHODOLOGIES
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1605 .
Autism Disorder and Treatment Market Segments:
Global Autism disorder and Treatment market has been segmented on the basis of types of treatment which comprises of Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder and others. On the basis of type of treatment which consists of neurofeedback , auditory integration training, chelation therapy, hyperbaric oxygen therapy, facilitated communication and others. On the basis on drugs which includes SSRIs, Anti-convulsants, Stimulants – Ritalin, Anti-psychotic, Risperidone and others.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future,
Office No. 528, Amanora Chambers,
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312